Chapter 607 If you want to get agency rights, you must compromise!
Qu Ping quickly followed Chen Xiao's request and immediately announced the relevant announcements and requirements for the global bidding for Changtian Technology's combined colony therapy and combined energy colony therapy.
At this moment, Bristol-Myers Squibb, Johnson & Johnson, Pfizer and other companies are still in Changzezhou and have not left.
The three companies did not expect Changtian Technology to play this trick.
However, this is an absolute benefit for the three companies.
Everyone knows that combined colony therapy and combined energy bacteria therapy are unique monopoly technologies in the world. One can complete the treatment of severe lung diseases, and the other can solve the problem of diabetes from the root.
If you can obtain agency rights, it will of course mean endless wealth in the future!
What’s the best money to make!
Of course, monopoly business is the most profitable.
After seeing Changtian Technology's announcement, companies such as Bristol-Myers Squibb and Pfizer immediately returned to the United States to prepare relevant materials.
In fact, the conditions proposed by Changtian Technology are easy to meet, but the most difficult to meet is the medical access qualification in the United States.
But when it comes to money, all options are available.
Pfizer has thought of it all.
On the one hand, Pfizer will definitely try its best to persuade the relevant departments in the United States, hoping that the combined colony therapy can be certified by the US FDA as soon as possible.
However, according to the efficiency of the United States, even if there are congressmen or capital to put pressure on the relevant departments of the United States, the process will be very long.
Therefore, Pfizer is preparing for two things. The second aspect is to go to the U.S. "colony" Puerto Rico or the backyard Mexico and other countries to promote the treatment plan first and let the American people receive the treatment.
Both Poland and Mexico are very close to the United States, and the laws here are not strict, so it is the best for medical treatment.
The solution is to think it through. What Pfizer wants now is to obtain the agency rights of Changtian Technology.
Companies such as Johnson & Johnson and Best-Myers Squibb also had this idea. They rushed home to report the relevant situation to the head office and prepare bidding materials.
Chen Xiao did not expect that one of his arrangements would cause the top ten pharmaceutical companies in the world to lose their legs.
But this arrangement of Changtian Technology has made relevant domestic departments nervous!
The relevant papers and clinical experimental results of Changtian Technology's combined colony therapy and combined energy bacteria therapy have been repeatedly studied and discussed by relevant national departments, and finally hundreds of pages of research results have been produced.
It would be too much space to describe hundreds of pages of research results. It can be summarized in two words——
That’s awesome!
After obtaining this result, the relevant departments immediately started the medical promotion process, including Changtian Technology's two combined colony treatment regimens as general treatment regimens, and applied to superiors to include the corresponding treatment costs in medical insurance.
However, the treatment cost of combined colony therapy is still relatively expensive, so it is not realistic to be included in medical insurance within a few years.
Even so, this is the best, or even the only, way to treat severe lung disease and diabetes.
Therefore, the relevant departments were very nervous when they learned that Changtian Technology was going to sell its treatment agency qualifications. They were very worried that the relevant treatment technology would once again be mastered by the West. Xiaguo Technology Company had finally won a position in the medical community
The right to speak was lost in this way.
Yang Kai, the person in charge of medical and health care, felt that he could not explain clearly what he said when he called Chen Xiao, so he quickly took a plane to Suhang City with his team, and then called a special car from Suhang City and rushed to Changchun City that day.
Zezhou and Chen Xiao meet.
Yang Kai came to Changzezhou in person, which flattered Chen Xiao a little.
Chen Xiao immediately received Yang Kai and his entourage ceremoniously in the conference room, thinking that Yang Kai was coming to visit the life science and medical laboratories of Changtian Technology to explore the therapeutic effects of combined exercise therapy.
Little did he know that Yang Kai never went to the laboratory or the treatment center, because through the papers published by Changtian Technology and the social reactions of patients who had received treatment, Yang Kai knew that the therapy of Changtian Technology was absolutely real.
Effective.
Yang Kai waved his hand and said to Chen Xiao: "Mr. Chen, our team is not here to visit your laboratory this time, nor is it to question whether your therapy is compliant or effective."
"Since the country allows you to open a treatment center in Changzezhou and allows you to treat patients on a large scale, it means that this treatment method is absolutely effective and approved by the country. We are here this time because we heard that your company will
I sold the treatment rights for combined exercise therapy and would like to know more about the situation.”
Yang Kai took a sip of tea and said: "We have passed all the certification procedures for combined colony therapy, and have planned to use this therapy as a standard treatment for severe lung diseases and diabetes. In the name of the national medical and health department, we will provide it to all hospitals across the country."
Hospitals and treatment centers will promote it, and we will also ask for your cooperation with Changtian Technology."
Chen Xiao probably knows the significance of this cooperation. It means that Changtian Technology's combined colony therapy will be promoted nationwide in the form of official certification. It also means that the combined therapy can truly and completely open up the domestic market.
.
In the future, Changtian Technology can dispatch medical personnel to every province to assist hospitals in cities under the province that are qualified to complete combined colony therapy to complete related treatment activities.
Of course, Changtian Technology must make the biggest profit among them.
Yang Kai said anxiously: "We know very well that combined colony therapy is a major breakthrough in the current biomedical field. Combined colony therapy can completely treat severe lung diseases, and combined energy bacteria can completely treat diabetes. The two
This treatment method is the first time in the history of international medicine, and we Xia people can have the right to speak!"
Yang Kai has worked in the health system for many years and is very aware of the importance of this right to speak.
International biomedical technology develops in a coordinated manner. It is not that one country or one company can master all the world's most advanced biomedical technologies by relying on its own strength.
But if you don’t have a trump card in your hand, you are not qualified to negotiate with other countries. If there are some indispensable life-saving treatments or drugs, the other country can sell them to you at a high price regardless of your feelings, and you have no bargaining whatsoever.
right.
But if you have one or two trump cards in your hand, you can negotiate with these Western countries and technology companies to form a win-win compromise for both parties.
In the past, Xia Guo's biomedical industry had very few trump cards, almost none at all. The so-called trump card was Xia Guo's large market.
Therefore, targeted anti-cancer drugs and high-end medical equipment from Western technology companies, especially American pharmaceutical companies, will be sold in Xia State at ridiculously high prices. Xia State has no choice but to accept them all.
Looking at Yang Kai and Chen Xiao who were so anxious, they smiled and said: "Only the agency rights in the United States, not technology transfer!"
"And to tell you the truth, Changtian Technology has invested a lot of money in chip research and development, and also hopes to obtain cash flow as quickly as possible through technology transfer to support the company's development."
"We also hope that through this cooperation with American pharmaceutical companies, we can gain more say for the national biomedical industry."
"If the country is willing, this time we can include a package of agreement conditions in our negotiations with an American company, including price reductions on some necessary drugs and medical equipment, etc."
Hearing Chen Xiao say this, Yang Kaicai really breathed a sigh of relief.
Yang Kai thought about it and felt that what Chen Xiao said was very reasonable.
Let Xia Guo's biomedical technology go out and let overseas patients feel that Xia Guo's medical technology is no worse than theirs. Only in this way can we gradually accumulate the reputation of Xia Guo's medical industry overseas, and can also make overseas seriously ill patients inseparable.
Kaixia's medical technology and related medicines.
Both parties must have mutual needs before they can further cooperate. Only in the future will the relevant departments of Xia State have a higher say in negotiations with American pharmaceutical companies.
Yang Kai said: "I will immediately formulate a different package of negotiation conditions for these three pharmaceutical companies."
Yang Kai has worked in the medical sector for many years and has dealt with Pfizer, Johnson & Johnson, Bristol-Myers Squibb and other companies many times, so they are very familiar with the scarce resources held by these pharmaceutical companies.
For example, some high-end medical equipment, antiviral drugs, anti-cancer drugs, etc.
As long as Chen Xiao cooperates with any of these companies, Yang Kai will put forward different requirements for them, so as to satisfy Xia Guo's medical market and save money for the country.
Chen Xiao and Yang Kai discussed for a long time, and the two sides decided on the final plan.
When Yang Kai left, he was full of emotions, "If Xia Guo can have more technology companies like Changtian Technology, there will be no need to worry about being unable to speak in the international medical industry."
Changtian Technology also provided a supplementary agreement for the public bidding for overseas agency rights based on the results of discussions with relevant departments.
In addition to meeting a package of negotiation conditions for Xia Guo's related pharmaceutical products and medical equipment, the lowest price for agency rights was also given.
No matter which company wins the bid, it will have to pay at least 3 billion U.S. dollars in agency fees. After the agency rights, the profit will be split 50-50.
The starting price of US$3 billion was given by Chen Xiao after careful consideration.
Because in 2006, the sales of several companies such as Pfizer exceeded 10 billion US dollars, of which Pfizer reached 30 billion US dollars. These companies also invest billions of US dollars in research and development expenses every year.
Therefore, offering an agency fee of US$3 billion is very uncomfortable for these companies, and it is a situation that may or may not be accepted.
If you don't accept it, then huge profits in the future will fall into the hands of others. But if you accept it, it will be quite painful to take out 3 billion yuan.
After Changtian Technology announced a package of negotiation conditions, some of these pharmaceutical companies collapsed.
Kassian listened to the quarrel between senior executives and shareholder representatives at the top-level meeting of BMS-Myers Squibb. After a quarrel, they still chose to compromise and were prepared to accept Changtian Technology's conditions.
But whether to invest 3 billion meters or to go up to 3 billion meters, everyone is a little hesitant.
Because if the price happens to be reported at US$3 billion, and if Pfizer and other companies offer a price of US$3 billion or higher, then Bristol-Myers Squibb will definitely not be able to win the bid.
The battle of wits and courage begins.
Bristol-Myers Squibb, Pfizer, Johnson & Johnson and other companies compete and cooperate in the pharmaceutical industry, but overall they are cooperative.
Especially in the international market, several American pharmaceutical companies, with the capital support behind them, are vigorously cooperating with each other to seize the market.
For example, Pfizer has developed a drug called Viagra to help men. This drug is very profitable, so companies such as Johnson & Johnson and Bristol-Myers Squibb will not develop similar drugs and cede the market to Pfizer.
Just as Bristol-Myers Squibb has developed anti-hepatitis drugs, Pfizer will be weaker in this regard and cede the market to Bristol-Myers Squibb.
Now Changtian Technology is asking these companies to compare prices with each other, which is indeed very painful for the three companies.
In the end, Pfizer took the initiative and negotiated with Johnson & Johnson and Guiba respectively. In the end, the three parties decided to bid for Changtian Technology at a price of 3 billion US dollars. After obtaining the US market, the three companies would allocate proportionally and share the benefits.
Right of agency.
One company's $1 billion contribution also eased the economic pressure on the three pharmaceutical companies.
The plan jointly drafted by the three companies was submitted to Changtian Technology.
After Chen Xiao saw this plan, he laughed and said: "They are doing this. I might as well not find an agent and continue to expand the combined colony therapy. At Xia Guo's treatment center, we welcome more Americans to come."
If you go to Xia Country for treatment, we can also build treatment centers in countries such as Mexico, which will be closer to the United States."
Chen Xiao said this, but he knew that it is actually quite difficult to operate in practice, especially it is unrealistic to build the treatment center in Mexico. After all, Mexico is the back garden of the United States, and Changtian Technology has nothing to do with the United States.
You will definitely be hindered in every possible way and will not be able to do this kind of thing.
But businessmen must use all their words when negotiating.
After learning that Changtian Technology had vetoed the decision, the three parties immediately sent a delegation to negotiate with Changtian Technology.
Chen Xiao was also happy. Anyway, he built the hospital in the United States and put the treatment technology in the United States to make money.
There is no essential difference between one agent and three agents in terms of Changtian Technology's profit, so Chen Xiao said: "Three agents will do, too. The agency fee will rise to 3.3 billion U.S. dollars. In addition, the other party must pay for the package provided by Xia Guo."
Negotiate an agreement and compromise!”
The package negotiation agreement given by the relevant departments of Xia Guo includes price reductions for Pfizer’s Lipitor, Norvasc, Celebrex, Viagra and other drugs, Bristol-Myers Squibb’s Insabepilone, Dasatinib and other drugs, as well as Johnson & Johnson’s drugs and equipment.
The requirements of the relevant departments of Xia State are actually not high. It is not that these drugs should be reduced to such a low level, but that the price level of these drugs should be comparable to that of the American or European markets.
After arduous negotiations, on the National Day of 2007.
Changtian Technology has reached a cooperation agreement with three pharmaceutical companies participating in the United States.
Three pharmaceutical companies in the United States spent a total of 3.3 billion US dollars to obtain the agency rights of Changtian Technology's combined colonies and combined energy bacteria therapy, and can carry out corresponding treatments in the United States and its territories.
After Yang Kai received the news in Yanjing, he, who was over fifty years old, raised his arms and shouted, and then shed tears of excitement.